256 related articles for article (PubMed ID: 10790596)
1. [The pharmacology of endothelin and its antagonist bosentan].
Clozel M; Roux S
Ann Endocrinol (Paris); 2000 Feb; 61(1):75-9. PubMed ID: 10790596
[TBL] [Abstract][Full Text] [Related]
2. Bosentan: a dual endothelin receptor antagonist.
Rubin LJ; Roux S
Expert Opin Investig Drugs; 2002 Jul; 11(7):991-1002. PubMed ID: 12084009
[TBL] [Abstract][Full Text] [Related]
3. Endothelin antagonism with bosentan: current status and future perspectives.
Ono K; Matsumori A
Cardiovasc Drug Rev; 2002; 20(1):1-18. PubMed ID: 12070530
[TBL] [Abstract][Full Text] [Related]
4. Bosentan and the endothelin system in congestive heart failure.
Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK
Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125
[TBL] [Abstract][Full Text] [Related]
5. [Remarkable response of bosentan, an endothelin receptor antagonist, for a patient with Eisenmenger syndrome].
Emoto N; Matsuo N; Ohnishi T; Miyagawa K; Kato H; Iwasa N; Yoshida A; Kawai H; Hirata K; Kuroda Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2549-51. PubMed ID: 19051748
[No Abstract] [Full Text] [Related]
6. [Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan].
Musch A
Med Monatsschr Pharm; 2006 Jul; 29(7):242-5. PubMed ID: 16866076
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
8. Endothelin antagonism with bosentan: a review of potential applications.
Roux S; Breu V; Ertel SI; Clozel M
J Mol Med (Berl); 1999 Apr; 77(4):364-76. PubMed ID: 10353441
[TBL] [Abstract][Full Text] [Related]
9. Endothelin and heart failure.
Nambi P; Clozel M; Feuerstein G
Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308
[TBL] [Abstract][Full Text] [Related]
10. [Endothelin].
Maeda S; Miyauchi T; Goto K
Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
[No Abstract] [Full Text] [Related]
11. Current status of bosentan for treatment of pulmonary hypertension.
Raja SG; Dreyfus GD
Ann Card Anaesth; 2008; 11(1):6-14. PubMed ID: 18182753
[TBL] [Abstract][Full Text] [Related]
12. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.
Rondelet B; Kerbaul F; Motte S; van Beneden R; Remmelink M; Brimioulle S; McEntee K; Wauthy P; Salmon I; Ketelslegers JM; Naeije R
Circulation; 2003 Mar; 107(9):1329-35. PubMed ID: 12628956
[TBL] [Abstract][Full Text] [Related]
13. Endothelin antagonists and heart failure.
Hürlimann D; Enseleit F; Noll G; Lüscher TF; Ruschitzka F
Curr Hypertens Rep; 2002 Feb; 4(1):85-92. PubMed ID: 11790297
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition.
Kaoukis A; Deftereos S; Raisakis K; Giannopoulos G; Bouras G; Panagopoulou V; Papoutsidakis N; Cleman MW; Stefanadis C
Curr Top Med Chem; 2013; 13(2):95-114. PubMed ID: 23470073
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.
Clozel M; Salloukh H
Ann Med; 2005; 37(1):2-12. PubMed ID: 15902842
[TBL] [Abstract][Full Text] [Related]
16. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
17. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Endothelin antagonism in heart failure.
Webb DJ
Circulation; 1995 Dec; 92(12):3372. PubMed ID: 8521551
[No Abstract] [Full Text] [Related]
18. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
Kuntzen C; Gülberg V; Gerbes AL
Gastroenterology; 2005 Jan; 128(1):164-8. PubMed ID: 15633133
[TBL] [Abstract][Full Text] [Related]
19. Endothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertension.
Kim NH; Rubin LJ
J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):9-19. PubMed ID: 12000973
[TBL] [Abstract][Full Text] [Related]
20. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
Sütsch G; Bertel O; Kiowski W
Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
